Evolent Health (EVH +14%) is up on double normal volume after its Q3 report released after the close yesterday. Highlights:
Revenue: $220.1M (+46.8%); Platform & operations services: $171.4M (+45.1%).
Net loss: ($25.5M) (-105.6%); loss/share: ($0.30) (-87.5%).
Non-GAAP EBITDA: $3,333M (-30.5%).
Cash consumption (9 mo.): ($55.8M) (-999%).
2019 guidance: Revenue: $838M – 850M from $825M – 850M; non-GAAP EBITDA: ($11.1M – 8.1M) from ($10.0M – 2.0M).
Previously: Evolent Health EPS beats by $0.03, beats on revenue (Nov. 5)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.